Clinical trial
Neurovascular Coupling, Clinical Outcomes, and NAD Supplementation in Parkinson's Disease
NCT07703137 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurovascular Coupling, Clinical Outcomes, and NAD Supplementation in Parkinson's Disease
- Lead sponsor
- University of Oklahoma
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- August 10, 2026
- Completion date
- July 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease